As of 2025-07-06, the Relative Valuation of Natco Pharma Ltd (NATCOPHARM.NS) is 2,922.88 INR. This relative valuation is based on P/E multiples. With the latest stock price at 998.60 INR, the upside of Natco Pharma Ltd based on Relative Valuation is 192.7%.
The range of the Relative Valuation is 1,612.93 - 3,729.99 INR.
| Range | Selected | |
| Trailing P/E multiples | 31.3x - 35.8x | 34.9x |
| Forward P/E multiples | 17.5x - 30.2x | 24.0x |
| Fair Price | 1,612.93 - 3,729.99 | 2,922.88 |
| Upside | 61.5% - 273.5% | 192.7% |
| Date | P/E |
| 2025-07-04 | 9.59 |
| 2025-07-03 | 9.32 |
| 2025-07-02 | 8.87 |
| 2025-07-01 | 8.98 |
| 2025-06-30 | 8.92 |
| 2025-06-27 | 8.51 |
| 2025-06-26 | 8.38 |
| 2025-06-25 | 8.47 |
| 2025-06-24 | 8.35 |
| 2025-06-23 | 8.38 |
| 2025-06-20 | 8.37 |
| 2025-06-19 | 8.40 |
| 2025-06-18 | 8.42 |
| 2025-06-17 | 8.37 |
| 2025-06-16 | 8.68 |
| 2025-06-13 | 8.79 |
| 2025-06-12 | 8.84 |
| 2025-06-11 | 9.00 |
| 2025-06-10 | 8.48 |
| 2025-06-09 | 8.30 |
| 2025-06-06 | 8.24 |
| 2025-06-05 | 8.28 |
| 2025-06-04 | 8.27 |
| 2025-06-03 | 8.28 |
| 2025-06-02 | 8.43 |
| 2025-05-30 | 8.48 |
| 2025-05-29 | 8.57 |
| 2025-05-28 | 8.34 |
| 2025-05-27 | 8.44 |
| 2025-05-26 | 8.45 |
| 2025-05-23 | 8.44 |
| 2025-05-22 | 8.42 |
| 2025-05-21 | 8.39 |
| 2025-05-20 | 8.21 |
| 2025-05-19 | 8.34 |
| 2025-05-16 | 8.08 |
| 2025-05-15 | 7.92 |
| 2025-05-14 | 7.96 |
| 2025-05-13 | 7.92 |
| 2025-05-12 | 8.05 |
| 2025-05-09 | 7.78 |
| 2025-05-08 | 7.69 |
| 2025-05-07 | 7.83 |
| 2025-05-06 | 7.97 |
| 2025-05-05 | 8.21 |
| 2025-05-02 | 8.06 |
| 2025-04-30 | 8.16 |
| 2025-04-29 | 8.48 |
| 2025-04-28 | 8.49 |
| 2025-04-25 | 8.55 |